To commemorate the merger of two industry leaders in preclinical histology, pathology and specimen archiving, we are thrilled to announce the launch of our new website highlighting the full breadth of our capabilities and footprint, as well as the debut of our new brand!
Formation of company to meet growing demand for high-quality histopathology services in the research and pre-clinical therapeutics markets includes growth equity investment from Ampersand Capital Partners
Immunohistochemistry (IHC) and immunofluorescence (IF) are molecular assays that involve the use of antibodies to detect specific proteins within tissues on microscope slides
The ability to convert glass microscope slides to high resolution, digital images and then perform morphometric image analysis is an important part of many preclinical research and development studies.
IHC is a valuable tool that can be used during most phases of drug development. It assists with target validation during early discovery projects and can help determine efficacy and safety during later phases of research and development.
Immunohistochemistry (IHC) is a molecular assay that involves the use of antibodies to detect specific proteins within tissues on microscope slides.
Creating slides is one of the most critical components of histology labs, but ensuring quality can sometimes slip if dealing with staff shortages
The success of preclinical drug research often hinges upon investigator engagement.
Keeping proper temperatures for your lab materials has perhaps become challenging lately as you face continual budget cuts.
Breast cancer is one of the most insidious diseases in the world, and doing pre-clinical trials to find a cure are likely a major goal for your company.
Date
March 10-14, 2019
Location
Baltimore Convention Center
Booth Number
#3637
Date
April 25, 2019
Location
Boston, MA
Date
April 29-May 1, 2019
Location
Atlanta
540. 477. 4440
